

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Lumacaftor ne-ivacaftor iyinhlanganisela yemithi eyenzelwe ngqo ukwelapha i-cystic fibrosis kubantu abanezinguquko ezithile zofuzo. Lokhu kwelashwa okusebenza kabili kusebenza ngokusiza amaprotheni anezinkinga emangqamuzeni akho ukuthi asebenze kangcono, okungathuthukisa ukusebenza kwamaphaphu futhi kunciphise ezinye izinkinga ze-cystic fibrosis.
Uma wena noma othandiweyo wakho unikezwe lo muthi, cishe ubhekene ne-cystic fibrosis futhi ufuna ulwazi olucacile, olusizayo mayelana nokuthi yini ongayilindela. Ake sihambe kukho konke okudingeka ukwazi ngalokhu kwelashwa okukhethekile ngamagama alula.
I-Lumacaftor ne-ivacaftor ngumuthi kadokotela ohlanganisa imithi emibili ukwelapha i-cystic fibrosis. Igama lomkhiqizo lale nhlanganisela yi-Orkambi, futhi yenzelwe ngqo abantu abanama-copy amabili e-F508del mutation ngaphakathi kofuzo lwabo lwe-CFTR.
Cabanga ngalo muthi njengeqembu elinamalungu amabili elisebenzisana emzimbeni wakho. I-Lumacaftor isiza ukuhambisa amaprotheni e-CFTR anezinkinga endaweni efanele emangqamuzeni akho, kuyilapho i-ivacaftor isiza lawa maprotheni ukuthi asebenze kangcono uma eselapho. Iprotheni ye-CFTR ibalulekile ekuhambiseni usawoti namanzi ngaphakathi nangaphandle kwamangqamuzana akho ngendlela efanele.
Lokhu akuyona ikhambi le-cystic fibrosis, kodwa kungasiza ukuthuthukisa ukuthi amaphaphu akho asebenza kanjani futhi kunganciphisa ezinye zezinkinga oziphathayo. Udokotela wakho uzobe ehlolile izakhi zofuzo zakho ukuze aqinisekise ukuthi unayo le mutation efanele ngaphambi kokukuyalela lo muthi.
Lo muthi usetshenziselwa ukwelapha i-cystic fibrosis kubantu abanama-copy amabili e-F508del mutation ngaphakathi kofuzo lwabo lwe-CFTR. Ivunyelwe iziguli ezineminyaka engu-2 ubudala nangaphezulu ngale makeup ethile yofuzo.
I-Cystic fibrosis ithinta indlela umzimba wakho okhiqiza ngayo amafinyila nomjuluko, okuholela emafinyileni aqinile, anamathelayo angavimba amaphaphu akho kanye nesistimu yokugaya ukudla. Ukuguqulwa kwe-F508del kuyimbangela ejwayelekile yezakhi zofuzo ye-cystic fibrosis, ethinta cishe u-70% wabantu abanesimo.
Udokotela wakho unqume lo muthi ngoba ukuhlolwa kwezakhi zofuzo kukhombise ukuthi unokuguqulwa okulungile ukuze lokhu kwelashwa kungasiza. Umgomo uwukuthuthukisa ukusebenza kwamaphaphu akho, ukunciphisa izimpawu zokuphefumula, futhi ukusize uzizwe ungcono.
Lo muthi ohlanganisiwe usebenza ngokugxila kuphrothini ye-CFTR enezinkinga ebangela izimpawu ze-cystic fibrosis. Kuthathwa njengokwelashwa okuqinile okulinganiselwe okubhekana nembangela eyinhloko yesimo kunokumane kulawule izimpawu.
Nakhu ukuthi ingxenye ngayinye isebenza kanjani emzimbeni wakho. I-Lumacaftor isebenza njengomsizi oqondisa amaprotheni e-CFTR anezinkinga ebusweni bamaseli akho lapho kudingeka abe khona. Abantu abaningi abane-F508del mutation banamaprotheni abambeka ngaphakathi kweseli futhi abalokothi baye lapho okufanele basebenze khona.
Khonamanjalo, i-ivacaftor isebenza njengokhiye osiza lawa maprotheni ukuthi asebenze kangcono uma esefinyelele ebusweni beseli. Isiza iziteshi zamaprotheni ukuthi zivuleke futhi zivale ngendlela efanele, okuvumela usawoti namanzi ukuthi adlule ngamaseli akho ngendlela ejwayelekile.
Ngokuhlanganyela, le mithi emibili ingasiza ekuthuthukiseni ukugeleza kukasawoti namanzi emaphashini akho nakwezinye izitho. Lokhu kungaholela emafinyileni ancane okulula ukuwasusa emaphashini akho nokusebenza okungcono kwezitho.
Thatha lo muthi ngendlela enqunywe ngayo udokotela wakho, ngokuvamile kabili ngosuku cishe ngamahora ayi-12 ahlukene. Kufanele ngaso sonke isikhathi uwuthathe nokudla okuqukethe amafutha, njengebhotela, ushizi, amantongomane, noma ubisi oluphelele, ngoba lokhu kusiza umzimba wakho ukuthi umunce umuthi ngendlela efanele.
Gwinya amaphilisi wonke ngengilazi yamanzi egcwele. Ungawachobozi, uwahlafune, noma uwaphule amaphilisi, ngoba lokhu kungathinta indlela umuthi osebenza ngayo emzimbeni wakho. Uma unenkinga yokugwinya amaphilisi, khuluma nodokotela wakho mayelana nezinketho zakho.
Zama ukuthatha imithamo yakho ngezikhathi ezifanayo nsuku zonke ukuze ikusize ukhumbule futhi ugcine amazinga aqhubekayo omuthi ohlelweni lwakho. Abantu abaningi bakuthola kusiza ukuthatha umthamo owodwa ekuseni kanye nomunye ngesidlo sakusihlwa.
Okuqukethwe ngamafutha ekudleni kwakho kubaluleke kakhulu kunalokho ongase ukucabange. Qondisa ukudla noma ukudla okulula okuqukethe okungenani amagremu angama-20 amafutha uma uthatha umuthi wakho. Lokhu kungabandakanya izinto ezinjengama-avocado, amaqanda aphekwe ngebhotela, noma inqwaba yamantongomane.
Lokhu ngokuvamile kuyindlela yokwelapha yesikhathi eside ozoqhubeka uyithatha uma nje ikusiza futhi ingabangeli imiphumela emibi. Abantu abaningi abane-cystic fibrosis badinga ukuthatha lo muthi unomphela ukuze bagcine izinzuzo.
Udokotela wakho uzoqapha intuthuko yakho njalo ngezivivinyo zomsebenzi wamaphaphu kanye nokuhlolwa okunye ukuze aqiniseke ukuthi umuthi uyakusebenzela. Abanye abantu babona ngcono ekuphefumuleni kwabo kanye namazinga amandla emasontweni ambalwa, kanti abanye bangase bathathe izinyanga eziningana ukuze babone izinguquko ezinkulu.
Ungayeki ukuthatha lo muthi ngokuzumayo ngaphandle kokukhuluma nodokotela wakho kuqala. Uma udinga ukuyeka nganoma yisiphi isizathu, udokotela wakho uzokuqondisa ngenqubo ngokuphepha. Izinzuzo zomuthi zingaphela ngokushesha uma uyeka ukuwuthatha.
Njengayo yonke imithi, i-lumacaftor ne-ivacaftor ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi emibi iyalawuleka, futhi abantu abaningi bathola ukuthi izinzuzo zidlula lokhu kungakhululeki kwesikhashana.
Nawa amanye imiphumela emibi evame kakhulu ongase uyithole, ikakhulukazi emasontweni akho ambalwa okuqala okwelashwa:
Le miphumela emibi ejwayelekile ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi. Uma ziqhubeka noma ziba yizithiyo, unganqikazi ukuxoxa ngazo nethimba lakho lokunakekelwa kwezempilo.
Abanye abantu bahlangabezana nemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha. Nakuba lokhu kungavamile, kubalulekile ukukwazi:
Xhumana nodokotela wakho ngokushesha uma uhlangabezana nanoma iyiphi yale miphumela emibi engathi sína. Ithimba lakho lokunakekelwa kwezempilo lizogada ukusebenza kwesibindi sakho nomfutho wegazi njalo ngenkathi uthatha lo muthi.
Lo muthi awulungile kuwo wonke umuntu, ngisho nakubantu abane-cystic fibrosis. Udokotela wakho uzohlola ngokucophelela ukuthi kuphephile futhi kufanelekile yini isimo sakho esithile.
Akufanele uthathe lo muthi uma unokungezwani komzimba ne-lumacaftor, ivacaftor, noma yiziphi ezinye izithako eziqukethwe emaphilisi. Udokotela wakho uzobuyekeza umlando wakho wokungezwani komzimba ngaphambi kokunquma lo muthi.
Abantu abanezimo ezithile zezokwelapha bangase badinge ukuqashwa okukhethekile noma bangase bangakwazi ukuthatha lo muthi ngokuphepha. Lezi zimo zihlanganisa:
Uma ukhulelwe noma uhlela ukukhulelwa, xoxa ngalokhu nodokotela wakho. Ngenkathi izifundo ezilwaneni zingakhombisanga ukulimala ezinganeni ezisakhula, alukho ulwazi olwanele mayelana nokuphepha ngesikhathi sokukhulelwa komuntu.
Lo muthi ungasebenzisana neminye imithi eminingi, ngakho qiniseka ukuthi udokotela wakho uyazi ngayo yonke imithi, izithasiselo, nemikhiqizo yamakhambi oyithathayo. Ezinye izindlela zokusebenzisana zingaba zimbi futhi zingadinga ukulungiswa kwemithamo noma ezinye izindlela zokwelapha.
Igama lomkhiqizo lalo muthi ohlanganisiwe yi-Orkambi. Leli yigama ozolibona ebhodleleni lakho likamuthi kanye nokupakishwa komuthi.
I-Orkambi yenziwa yi-Vertex Pharmaceuticals futhi iyona kuphela umkhiqizo otholakala njengamanje ngale nhlanganisela ethile ye-lumacaftor kanye ne-ivacaftor. Azikho izinhlobo ezivamile ezitholakalayo ngalesi sikhathi.
Uma ukhuluma nethimba lakho lezempilo noma usokhemisi, ungabhekisa kumuthi wakho ngokuthi “lumacaftor kanye ne-ivacaftor” noma “Orkambi” futhi bazokwazi kahle ukuthi usho ukuthini.
Uma i-lumacaftor kanye ne-ivacaftor ingakulungele, zikhona ezinye izidakamizwa ze-CFTR modulator ezitholakalayo kubantu abane-cystic fibrosis, kuye ngokuguqulwa kwakho okuthile kwezakhi zofuzo.
I-Trikafta (elexacaftor, tezacaftor, kanye ne-ivacaftor) iyinhlanganisela entsha yemithi emithathu esebenza kubantu okungenani abanoshintsho olulodwa lwe-F508del. Odokotela abaningi manje bakhetha i-Trikafta ngoba ivame ukunikeza imiphumela engcono enemiphumela emincane kuno-Orkambi.
Ezinye izindlela zokwelapha zihlanganisa i-Kalydeco (ivacaftor yodwa) kubantu abanoshintsho oluthile lwe-gating, kanye ne-Symdeko (tezacaftor kanye ne-ivacaftor) kubantu abanoshintsho oluthile. Udokotela wakho uzoqoka ukuthi yimuphi umuthi ongcono kakhulu ngokusekelwe emiphumeleni yakho yokuhlolwa kwezakhi zofuzo.
Ukwelashwa kwendabuko kwe-cystic fibrosis okufana namasu okuhlanza umoya, imithi ephefumulwayo, nama-enzyme e-pancreatic kusabalulekile ohlelweni lwakho lokunakekelwa, kungakhathaliseki ukuthi iyiphi i-CFTR modulator oyithathayo.
I-Trikafta ngokuvamile ithathwa njengephumelela kakhulu kune-lumacaftor ne-ivacaftor kubantu abaningi abafanelekayo kokubili imithi. Izifundo zomtholampilo zikhombise ukuthi i-Trikafta ngokuvamile inikeza ngcono okukhulu ekusebenzeni kwamaphaphu nasekuthuthukiseni izinga lempilo.
Abantu abaningi abashintsha besuka e-Orkambi baya e-Trikafta bathola imiphumela engcono enemiphumela emibi embalwa. I-Trikafta isebenza kubantu okungenani abanoshintsho olulodwa lwe-F508del, kuyilapho i-Orkambi idinga amakhophi amabili alolu shintsho.
Nokho, umuthi
Uma ngabe uthathe umuthi omningi kunalowo odokotela abakuqokele wona, xhumana nodokotela wakho noma isikhungo sokulawula ubuthi ngokushesha. Ungalindi ukubona ukuthi uzizwa kanjani, ngoba eminye imiphumela yokweqisa umuthi ingase ingaveli ngokushesha.
Ngesikhathi ulindele iseluleko sezokwelapha, phuza amanzi amaningi futhi gwema ukuthatha eminye imithi. Uma unzima ukuphefumula, ubuhlungu besifuba, noma ezinye izimpawu ezinzima, shayela ku-911 noma uye egumbini eliphuthumayo eliseduze ngokushesha.
Uma uphuthelwa umthamo futhi sekudlule amahora angaphansi kwangu-6 kusukela lapho obufanele uwuthathe ngayo, thatha umthamo owuphuthelwe nokudla okunamfuthu ngokushesha lapho ukhumbula. Uma sekudlule amahora angaphezu kwangu-6, weqa umthamo owuphuthelwe bese uthatha umthamo wakho olandelayo ngesikhathi esijwayelekile.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo owuphuthelwe, ngoba lokhu kungakhuphula ingozi yakho yemiphumela emibi. Uma uvame ukukhohlwa imithamo, cabangela ukusetha izikhumbuzi zocingo noma ukusebenzisa umhleli wamaphilisi ukukusiza ukuthi uhlale emgwaqeni.
Kufanele uyeke kuphela ukuthatha lo muthi ngaphansi kwesiqondiso sikadokotela wakho. Lokhu ngokuvamile kuyindlela yokwelapha yesikhathi eside, futhi ukuwuyeka kungabangela ukuthi izimpawu zakho ze-cystic fibrosis zibuye ngokushesha.
Udokotela wakho angase ancome ukuyeka uma uhlangabezana nemiphumela emibi engathi sína, uma umuthi ungakusizi, noma uma ushintshela kwenye i-CFTR modulator. Bazokwenza uhlelo lokuyeka ngokuphepha nokuqapha impilo yakho ngesikhathi sokushintsha.
Yebo, cishe uzoqhubeka nokuthatha eminye imithi yakho ye-cystic fibrosis kanye ne-lumacaftor kanye ne-ivacaftor. Lokhu kuhlanganisa izinto ezinjenge-enzyme ye-pancreatic, imithi ephefumulwayo, namavithamini.
Noma kunjalo, eminye imithi ingase ihlangane ne-lumacaftor kanye ne-ivacaftor, okungenzeka ukuthi yenza ingasebenzi kahle noma yandise imiphumela emibi. Hlala utshela udokotela wakho ngayo yonke imithi kanye nezithasiselo ozithathayo ukuze bakwazi ukuhlola ukuthi akukho yini ukuhlangana futhi balungise imithamo uma kudingeka.
Get clear medical guidance
on symptoms, medications, and lab reports.